market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Source depth averages 2 original sources per story, versus 5.1 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about SaaS
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Source depth averages 2 original sources per story, versus 5.1 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 6.1 for that window. SaaS appears in 1 tracked Healthcare story from March 13, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering SaaS. Shared-story counts are live from our verified record — not editorial picks.
Market commentator Josh Brown identifies biotechnology as a unique growth sector shielded from the deflationary pressures of artificial intelligence. Unlike software, biotech's regulatory and physical barriers create a durable moat that AI accelerates rather than disrupts.